Psychedelic Stocks Soar on Trump's Research Order

April 20, 2026·about 3 hours ago·via Forbes

Psychedelic stocks surge after Trump signs an order fast-tracking drug research, unleashing market innovation against FDA strangleholds. This bold move champions individual liberty and medical breakthroughs over nanny-state bans that block American progress. Investors cheer as Trump's deregulation drives real science forward, sidelining liberal moralizing. It's proof that free markets heal faster than government roadblocks ever could. Read more about this...

Related Coverage

WebsiteSara Gonzales exposes Maine school for inviting sexually charged queer dancer to perform for middle and high school kids — The Blaze

WebsiteKash Patel says 2020 election fraud arrests are 'coming soon' — The Blaze

SubstackTrump’s Not Paying Attention to His Own War — The Bulwark

WebsiteFTC orders pest-control company to cease employees' noncompete agreements — Washington Times

WebsiteStrait of Hormuz: Why Iran’s Small Speed Boats Are Difficult to Defend Against — The Gateway Pundit

WebsiteEliminating Fraud At The Forefront of President’s Agenda — The Gateway Pundit

WebsiteIran's Last Chance To Avoid Finding Out What's Behind Door Number B-2 — Hot Air